2011 NLA Scientific Sessions Highlights
Clinical Trial Updates Impacting Your Practice
What Do Simple Genetics Tell Us About Complex Diseases?
The Impact of Prescription Switching on LDL-C Goal Attainment
JoAnne M. Foody, MD, FACC, FAHA
Dr Foody focused on the unintended consequences of formulary changes and the potentially harmful effects, with respect to providing evidence-based care or meeting therapeutic goals. She noted that in the United Kingdom (UK), forced switching of high-dose to low-dose statin resulted in higher rates of death, cardiac death, and non-cardiac death in individuals switched to the lower dose.
Common Etiologies of Hypertriglyceridemia
Henry N. Ginsberg, MD
At least 95% of people with type-2 diabetes are insulin resistant. In the adipose tissue, insulin-resistant cells release fatty acids, increasing fatty acid flux to the liver resulting in transformation of the excess into triglycerides (TG)